Your browser doesn't support javascript.
loading
DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
Ferguson, Bradley S; Wennersten, Sara A; Demos-Davies, Kimberly M; Rubino, Marcello; Robinson, Emma L; Cavasin, Maria A; Stratton, Matthew S; Kidger, Andrew M; Hu, Tianjing; Keyse, Stephen M; McKnight, Robert A; Lane, Robert H; Nozik, Eva S; Weiser-Evans, Mary C M; McKinsey, Timothy A.
Afiliación
  • Ferguson BS; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Wennersten SA; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Demos-Davies KM; Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Rubino M; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Robinson EL; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Cavasin MA; Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Stratton MS; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Kidger AM; Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Hu T; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Keyse SM; Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • McKnight RA; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Lane RH; Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Nozik ES; Stress Response Laboratory, Division of Cellular Medicine, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Dundee, United Kingdom.
  • Weiser-Evans MCM; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • McKinsey TA; Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Am J Physiol Heart Circ Physiol ; 321(2): H382-H389, 2021 08 01.
Article en En | MEDLINE | ID: mdl-34142888
Pulmonary hypertension (PH) is associated with structural remodeling of pulmonary arteries (PAs) because of excessive proliferation of fibroblasts, endothelial cells, and smooth muscle cells (SMCs). The peptide hormone angiotensin II (ANG II) contributes to pulmonary vascular remodeling, in part, through its ability to trigger extracellular signal-regulated kinase (ERK1/2) activation. Here, we demonstrate that the ERK1/2 phosphatase, dual-specificity phosphatase 5 (DUSP5), functions as a negative regulator of ANG II-mediated SMC proliferation and PH. In contrast to wild-type controls, Dusp5 null mice infused with ANG II developed PH and right ventricular (RV) hypertrophy. PH in Dusp5 null mice was associated with thickening of the medial layer of small PAs, suggesting an in vivo role for DUSP5 as a negative regulator of ANG II-dependent SMC proliferation. Consistent with this, overexpression of DUSP5 blocked ANG II-mediated proliferation of cultured human pulmonary artery SMCs (hPASMCs) derived from patients with idiopathic PH or from failed donor controls. Collectively, the data support a role for DUSP5 as a feedback inhibitor of ANG II-mediated ERK signaling and PASMC proliferation and suggest that disruption of this circuit leads to adverse cardiopulmonary remodeling.NEW & NOTEWORTHY Dual-specificity phosphatases (DUSPs) serve critical roles in the regulation of mitogen-activated protein kinases, but their functions in the cardiovascular system remain poorly defined. Here, we provide evidence that DUSP5, which resides in the nucleus and specifically dephosphorylates extracellular signal-regulated kinase (ERK1/2), blocks pulmonary vascular smooth muscle cell proliferation. In response to angiotensin II infusion, mice lacking DUSP5 develop pulmonary hypertension and right ventricular cardiac hypertrophy. These findings illustrate DUSP5-mediated suppression of ERK signaling in the lungs as a protective mechanism.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Arteria Pulmonar / Hipertrofia Ventricular Derecha / Miocitos del Músculo Liso / Proliferación Celular / Fosfatasas de Especificidad Dual / Remodelación Vascular / Ventrículos Cardíacos / Hipertensión Pulmonar Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Am J Physiol Heart Circ Physiol Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Arteria Pulmonar / Hipertrofia Ventricular Derecha / Miocitos del Músculo Liso / Proliferación Celular / Fosfatasas de Especificidad Dual / Remodelación Vascular / Ventrículos Cardíacos / Hipertensión Pulmonar Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Am J Physiol Heart Circ Physiol Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2021 Tipo del documento: Article